U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.974G>T (p.Gly325Val) AND Li-Fraumeni syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Feb 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000232570.12

Allele description [Variation Report for NM_000546.6(TP53):c.974G>T (p.Gly325Val)]

NM_000546.6(TP53):c.974G>T (p.Gly325Val)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.974G>T (p.Gly325Val)
HGVS:
  • NC_000017.11:g.7673554C>A
  • NG_017013.2:g.18997G>T
  • NM_000546.6:c.974G>TMANE SELECT
  • NM_001126112.3:c.974G>T
  • NM_001126113.3:c.974G>T
  • NM_001126114.3:c.974G>T
  • NM_001126115.2:c.578G>T
  • NM_001126116.2:c.578G>T
  • NM_001126117.2:c.578G>T
  • NM_001126118.2:c.857G>T
  • NM_001276695.3:c.857G>T
  • NM_001276696.3:c.857G>T
  • NM_001276697.3:c.497G>T
  • NM_001276698.3:c.497G>T
  • NM_001276699.3:c.497G>T
  • NM_001276760.3:c.857G>T
  • NM_001276761.3:c.857G>T
  • NP_000537.3:p.Gly325Val
  • NP_000537.3:p.Gly325Val
  • NP_001119584.1:p.Gly325Val
  • NP_001119585.1:p.Gly325Val
  • NP_001119586.1:p.Gly325Val
  • NP_001119587.1:p.Gly193Val
  • NP_001119588.1:p.Gly193Val
  • NP_001119589.1:p.Gly193Val
  • NP_001119590.1:p.Gly286Val
  • NP_001263624.1:p.Gly286Val
  • NP_001263625.1:p.Gly286Val
  • NP_001263626.1:p.Gly166Val
  • NP_001263627.1:p.Gly166Val
  • NP_001263628.1:p.Gly166Val
  • NP_001263689.1:p.Gly286Val
  • NP_001263690.1:p.Gly286Val
  • LRG_321t1:c.974G>T
  • LRG_321:g.18997G>T
  • LRG_321p1:p.Gly325Val
  • NC_000017.10:g.7576872C>A
  • NM_000546.4:c.974G>T
  • NM_000546.5:c.974G>T
  • P04637:p.Gly325Val
  • p.G325V
Protein change:
G166V; GLY325VAL
Links:
UniProtKB: P04637#VAR_006039; OMIM: 191170.0021; dbSNP: rs121912659
NCBI 1000 Genomes Browser:
rs121912659
Molecular consequence:
  • NM_000546.6:c.974G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.974G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.974G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.974G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.578G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.578G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.578G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.857G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.857G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.857G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.497G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.497G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.497G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.857G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.857G>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000285218Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Feb 1, 2024)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

SCV004823740All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Nov 2, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown2not providednot provided108544not providedclinical testing

Citations

PubMed

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.

Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, Gianferante M, Spector LG, Morton LM, Karyadi D, Robison LL, Armstrong GT, Bhatia S, Song L, Pankratz N, Pinheiro M, Gastier-Foster JM, Gorlick R, de Toledo SRC, Petrilli AS, Patino-Garcia A, Lecanda F, et al.

JAMA Oncol. 2020 May 1;6(5):724-734. doi: 10.1001/jamaoncol.2020.0197.

PubMed [citation]
PMID:
32191290
PMCID:
PMC7082769

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.

Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, Hopf TA, Marks DS, Oren M, Segal E.

Mol Cell. 2018 Jul 5;71(1):178-190.e8. doi: 10.1016/j.molcel.2018.06.012. Erratum in: Mol Cell. 2018 Sep 6;71(5):873. doi: 10.1016/j.molcel.2018.08.013.

PubMed [citation]
PMID:
29979965
See all PubMed Citations (13)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000285218.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 325 of the TP53 protein (p.Gly325Val). This variant is present in population databases (rs121912659, gnomAD 0.0009%). This missense change has been observed in individual(s) with colon carcinoma, Li-Fraumeni syndrome, non-Hodgkin lymphoma, and/or osteosarcoma (PMID: 1565144, 29955864, 32191290). ClinVar contains an entry for this variant (Variation ID: 12367). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 12826609, 29979965, 30224644) indicates that this missense variant is not expected to disrupt TP53 function with a negative predictive value of 97.5%. Experimental studies have shown that this missense change does not substantially affect TP53 function (PMID: 12826609, 16007150, 20128691, 21343334, 29955864, 30224644). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004823740.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (10)

Description

This missense variant replaces glycine with valine at codon 325 of the TP53 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Experimental functional studies have shown this variant to behave as wild-type in transcriptional transactivation and human cell growth suppression assays (PMID: 12826609, 16007150, 17606709, 21343334, 29955864, 30224644, but has also shown moderate impact in DNA binding and apoptosis assays (PMID: 10629033, 20128691). This variant has been reported in an individual affected with non-Hodgkin lymphoma and colon cancer in the literature (PMID: 1565144). This variant has been identified in 1/251420 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided2not providednot providednot provided

Last Updated: Sep 29, 2024